Hydration Strategies For ZOMETA® Therapy For Tumour-Induced Hypercalcaemia (TIH)

View videos on bone
metastases and the ZOMETA
mechanism of action

Learn more about the ZOMETA(zoledronic acid) mechanism of action

For non-U.S. Healthcare Professionals: Get information about ZOMETA and its product characteristics

Learn more about ZOMETA product characteristics

Zometa Dosing & Administration: Dosing for TIH

ZOMETA is the current standard of care for the prevention of skeletal-related events (SREs)

Hydration is key to the success of treating TIH

Because TIH causes severe fluid imbalances, maintaining proper hydration during treatment is critical²
Patients should be assessed before administration of ZOMETA^® to ensure they are properly hydrated¹
Vigorous saline hydration should be employed to bring urine output to approximately 2 L/day³
Overhydration should be avoided in patients at risk for cardiac failure¹

Disclaimer: This is an international website for ZOMETA^® (zoledronic acid) and is intended for healthcare professionals outside the US. If you are a US resident, please click on the US flag at the top right corner of this page. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.